¼¼°èÀÇ ÀǾàǰ ¼öŹÁ¦Á¶ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® : Á¦Ç°º°, ÀǾàǰº°, ¼­ºñ½ºº°, »ç¾÷ ±Ô¸ðº°, ¿öÅ©Ç÷ο캰, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, ±â¾÷ ±Ô¸ðº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)
Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report By Product, By Drug, By Service, By Scale of Operation, By Workflow, By Application, By End Use, By Company, By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1678668
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 150 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,609,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,055,000
Printable PDF (5-User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,949,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÀǾàǰ ¼öŹÁ¦Á¶ ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽЏ®Æ÷Æ®¿¡ µû¸£¸é ¼¼°èÀÇ ÀǾàǰ ¼öŹÁ¦Á¶ ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 2,245¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

ÀÌ ½ÃÀåÀº 2025-2030³â ¿¬Æò±Õ 9.84%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ½ÃÀåÀÇ ¼ºÀå ±âȸ´Â ºñ¿ë È¿À²¼º, ¼öŹÁ¦Á¶ ½Ã¼³À» Ȱ¿ëÇÑ »ý»ê È¿À²È­, ÇÙ½É ¿ª·®¿¡ ÁýÁßÇÒ ¼ö ÀÖ´Â ±âȸ µî Á¦¾à±â¾÷ÀÌ ´©¸± ¼ö ÀÖ´Â ÀÌÁ¡¿¡ ±âÀÎÇÕ´Ï´Ù. ¶ÇÇÑ »ý¹°Á¦Á¦, ¹ÙÀÌ¿À½Ã¹Ð·¯, °íȰ¼º ÀǾàǰ ¼ººÐ(HPAPI), ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

Á¦¾à±â¾÷ÀÇ ½ÅÁ¦Ç° Çõ½ÅÀ¸·ÎÀÇ ÁøÃâÀº ÀÓ»ó½ÃÇè, Æ÷Àå, ±ÔÁ¦ Áؼö¸¦ À§ÇÑ ¼öŹÁ¦Á¶(CMO) ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ¿¬¼Ó »ý»ê, ÀÚµ¿È­, AI¸¦ ÅëÇÑ °øÁ¤ ÃÖÀûÈ­ µî CMO °£ÀÇ ±â¼ú ÅëÇÕÀº ÀǾàǰ Á¦Á¶¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº È¿À²¼ºÀ» ³ôÀ̰í, ³¶ºñ¸¦ ÁÙÀ̸ç, Á¦Ç°ÀÇ Ç°Áú°ú Ç¥ÁØÀ» Çâ»ó½Ãŵ´Ï´Ù.

CMO ÇÁ·Î¹ÙÀÌ´õ´Â ±â¾÷ÀÌ FDA, EMA, ICHÀÇ ±ÔÁ¦ ¿ä°ÇÀ» ÃæÁ·ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¹Ç·Î ÀǾàǰ ¼öŹÁ¦Á¶ »ê¾÷Àº ¿¹Ãø ±â°£ Áß Áö¼ÓÀûÀÎ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ºê·£µå ÀǾàǰ°ú Á¦³×¸¯ ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ´Â °Íµµ ÀǾàǰ ¼öŹÁ¦Á¶ »ê¾÷ÀÇ ¼ºÀå¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. ´Ù¾çÇÑ Á¦³×¸¯ ÀǾàǰÀÇ Æ¯Çã°¡ ¸¸·áµÇ´Â °¡¿îµ¥, Á¦¾à»çµéÀº ÀÌ·¯ÇÑ ¼ö¿ä¿¡ ´ëÀÀÇϱâ À§ÇØ »õ·Î¿î Á¦³×¸¯ ÀǾàǰÀ» °³¹ßÇϰí ÀÖ½À´Ï´Ù. µû¶ó¼­ ¸¹Àº Á¦¾àȸ»çµéÀº ½ÃÀåÀÇ ¿ä±¸¸¦ È¿À²ÀûÀ̰í È¿°úÀûÀ¸·Î ÃæÁ·½Ã۱â À§ÇØ CMO ¼­ºñ½º¿¡ ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ ±ÔÁ¦´Â ÀǾàǰÀÇ Áß¿äÇÑ ¿ä¼Ò Áß ÇϳªÀ̸ç, FDA´Â ÀǾàǰÀÇ ¾ÈÀü¼º°ú È¿À²¼ºÀ» º¸ÀåÇÏ´Â µ¥ ÀÖÀ¸¸ç, ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ÀǾàǰ ¼öŹÁ¦Á¶¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àü·«Àû ÆÄÆ®³Ê½Ê°ú Á¦Ç° Ãâ½ÃÀÇ °¡¼ÓÈ­µµ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 12¿ù, ·ÐÀÚ´Â Çõ½ÅÀûÀΠĸ½¶ ±â¾÷ÀÇ µ¶ÀÚÀûÀÎ °³¹ß ¹× Á¦Á¶ ¿ä±¸¸¦ Áö¿øÇϱâ À§ÇØ °æ±¸¿ë »ý¹°Á¦Á¦ ¼­ºñ½º Á¦°øÀ» È®´ëÇÑ´Ù°í ¹àÇû½À´Ï´Ù. ÀÌ Á¦Ç°ÀÇ Ãâ½Ã·Î ȯÀÚµéÀº »ýü ÀÌ¿ë·ü ¹®Á¦¸¦ ¿ÏÈ­ÇÒ ¼ö ÀÖ´Â Çõ½ÅÀûÀÎ Àü´Þ ¼Ö·ç¼ÇÀ» °í·ÁÇÒ ¼ö ÀÖ°Ô µË´Ï´Ù.

ÀǾàǰ ¼öŹÁ¦Á¶ ½ÃÀå : ºÐ¼® °³¿ä

¸ñÂ÷

Á¦1Àå ºÐ¼® ¹æ¹ý¡¤¹üÀ§

Á¦2Àå °³¿ä

Á¦3Àå ÀǾàǰ ¼öŹÁ¦Á¶ ½ÃÀå : º¯µ¿ ¿äÀΡ¤µ¿Ç⡤¹üÀ§

Á¦4Àå ÀǾàǰ ¼öŹÁ¦Á¶ ½ÃÀå : ¼­ºñ½ºº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå ÀǾàǰ ¼öŹÁ¦Á¶ ½ÃÀå : Á¦Ç°º° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå ÀǾàǰ ¼öŹÁ¦Á¶ ½ÃÀå : ÀǾàǰº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦7Àå ÀǾàǰ ¼öŹÁ¦Á¶ ½ÃÀå : »ç¾÷ ±Ô¸ðº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦8Àå ÀǾàǰ ¼öŹÁ¦Á¶ ½ÃÀå : ¿öÅ©Ç÷ο캰 ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦9Àå ÀǾàǰ ¼öŹÁ¦Á¶ ½ÃÀå : ¿ëµµº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦10Àå ÀǾàǰ ¼öŹÁ¦Á¶ ½ÃÀå : ÃÖÁ¾ ¿ëµµº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦11Àå ÀǾàǰ ¼öŹÁ¦Á¶ ½ÃÀå : ±â¾÷ ±Ô¸ðº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦12Àå ÀǾàǰ ¼öŹÁ¦Á¶ ½ÃÀå : Áö¿ªº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦13Àå °æÀï ±¸µµ

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Pharmaceutical Contract Manufacturing Market Growth & Trends:

The global pharmaceutical contract manufacturing market size is expected to reach USD 224.51 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to grow at a CAGR of 9.84% from 2025 to 2030. Growth in the market can be attributed to benefits offered to pharmaceutical companies, such as cost efficiencies, the ability to leverage contract manufacturing facilities to streamline production, and the opportunity to focus on core competencies. In addition, the market is driven by the increasing demand for biologics, biosimilars, high-potency active pharmaceutical ingredients (HPAPIs), and personalized medicine.

The expansion of pharmaceutical companies into new product innovations has led to the increased demand for contract manufacturing organization (CMO) services for clinical trials, packaging, and regulatory compliance. Technological integrations among CMOs, such as continuous manufacturing, automation, and AI-driven process optimization, are further propelling pharmaceutical production. These innovations enhance efficiency, reduce waste, and improve product quality and standards.

The pharmaceutical contract manufacturing industry is expected to experience continued growth during the forecast period, as CMO providers play a crucial role in helping companies meet the regulatory requirements of the FDA, EMA, and ICH. Moreover, the growing demand for both branded and generic drugs is a significant factor in the expansion of the pharmaceutical contract manufacturing industry. As various generic drugs reach patent expiration, pharmaceutical companies are innovating new generic versions to meet this demand. Hence, many of these pharmaceutical companies are relying on CMO services to fulfill market needs efficiently and effectively.

In addition, regulation is one of the significant factors for pharmaceutical products that have fueled the demand for pharmaceutical contract manufacturing. The FDA plays a pivotal role in ensuring the safety and efficiency of pharmaceuticals in the market. Likewise, strategic partnerships and accelerating product launches drive market growth. For instance, in December 2024, Lonza mentioned the expansion of its service offering orally delivered biologic therapies to support innovative capsule companies' unique development and manufacturing needs. The product launch will help patients explore innovative delivery solutions to mitigate bioavailability challenges.

Pharmaceutical Contract Manufacturing Market Report Highlights:

Table of Contents

Chapter 1. Research Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Pharmaceutical Contract Manufacturing Market Variables, Trends & Scope

Chapter 4. Pharmaceutical Contract Manufacturing Market: Service Estimates & Trend Analysis

Chapter 5. Pharmaceutical Contract Manufacturing Market: Product Estimates & Trend Analysis

Chapter 6. Pharmaceutical Contract Manufacturing Market: Drug Estimates & Trend Analysis

Chapter 7. Pharmaceutical Contract Manufacturing Market: Scale of Operation Estimates & Trend Analysis

Chapter 8. Pharmaceutical Contract Manufacturing Market: Workflow Estimates & Trend Analysis

Chapter 9. Pharmaceutical Contract Manufacturing Market: Application Estimates & Trend Analysis

Chapter 10. Pharmaceutical Contract Manufacturing Market: End Use Estimates & Trend Analysis

Chapter 11. Pharmaceutical Contract Manufacturing Market: Company Size Estimates & Trend Analysis

Chapter 12. Pharmaceutical Contract Manufacturing Market: Regional Estimates & Trend Analysis

Chapter 13. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â